India Pharma Sector: Duty Waivers ke baad bhi Supply Chain mein Tension! Kya hai asli problem?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
India Pharma Sector: Duty Waivers ke baad bhi Supply Chain mein Tension! Kya hai asli problem?
Overview

Bhai log, India ke pharma companies ko abhi bhi raw materials ki supply line mein kaafi dikkat aa rahi hai. Sarkar ne **40+** products par customs duty maaf kar di hai **June 30** tak, lekin asli problem cost kam hone ki nahi, balki time pe shipments milne ki hai. Saudi ki SABIC ne kuch zaroori cheezon par 'force majeure' laga diya hai, jisse aur tension badh gaya hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Aakhir supply chain mein itni problems kyun?

Toh sabse pehle baat karte hain supply chain ki. West Asia mein chal rahe tension ke beech pharma companies ke liye petrochemical inputs ki smooth supply sabse important hai. Haan, sarkar ne 40 se zyada zaroori items par customs duty June 30 tak hata di hai jisse cost kam ho sakti hai, lekin asli problem toh mal material physically milne aur time par usse use karne ki hai.

Geopolitical Headwinds se aur Bigaada Maahol

Ab ismein add ho jate hain global geopolitics ke issues. Strait of Hormuz aur Red Sea jaise important shipping routes par problems ki wajah se supply chains aur fragile ho gayi hain. Socho, Saudi ki badi chemical company SABIC ne methanol aur styrene jaise materials par 'force majeure' declare kar diya hai! Matlab, woh ab supply nahi kar paayenge.

Is wajah se bahut saari ships ab lambi routes le rahi hain, jaise Cape of Good Hope ke aas paas se. Isse delivery mein hafton ka delay ho raha hai, aur companies ke stock levels par pressure aa raha hai.

Govt ka support aur Export ko boost

Government ne jo duty waiver di hai, usmein anhydrous ammonia, methanol, styrene, aur alag-alag polymers jaise cheezein shamil hain. Ye sab June 30 tak valid hai, taaki badhti hui prices ka impact thoda kam ho. Pharma export promotion council (Pharmexcil) ne is relief ko welcome toh kiya hai, lekin unka kehna hai ki asli fayda tabhi hoga jab global prices stable rahein.

Aur ek achhi khabar yeh hai ki RoDTEP scheme ko bhi pehle jaisa hi restore kar diya gaya hai. Isse India ke medical device aur pharma exporters ko global market mein better compete karne mein help milegi.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.